HOOKIPA Pharma Newsroom

HOOKIPA Pharma Cut to Sector Perform From Outperform by RBC Capital

Dow JonesDec 20 09:21 ET

RBC Downgrades HOOKIPA Pharma to Sector Perform From Outperform, Slashes Price Target to $2 From $48, Keeps Speculative Risk

MT NewswiresDec 20 06:18 ET

HOOKIPA Pharma Price Target Cut to $7.00/Share From $24.00 by JMP Securities

Dow JonesNov 21 07:38 ET

HOOKIPA Pharma Analyst Ratings

BenzingaNov 21 07:29 ET

JMP Securities Maintains HOOKIPA Pharma(HOOK.US) With Buy Rating, Cuts Target Price to $7

Moomoo NewsNov 21 00:32 ET

Strategic Shift and Partnership Potential Drive Buy Rating for HOOKIPA Pharma

TipRanksNov 21 00:29 ET

Analysts Are Bullish on These Healthcare Stocks: Hookipa Pharma (HOOK), Cue Biopharma (CUE)

TipRanksNov 18 00:41 ET

JMP Securities Maintains HOOKIPA Pharma(HOOK.US) With Buy Rating, Maintains Target Price $24

Moomoo NewsNov 18 00:32 ET

HOOKIPA Pharma Is Maintained at Outperform by RBC Capital

Dow JonesNov 15 12:45 ET

HOOKIPA Pharma Analyst Ratings

BenzingaNov 15 12:34 ET

JMP Securities Maintains HOOKIPA Pharma(HOOK.US) With Buy Rating, Maintains Target Price $24

Moomoo NewsNov 11 11:32 ET

Analysts Offer Insights on Healthcare Companies: Hookipa Pharma (HOOK) and SCYNEXIS (SCYX)

TipRanksNov 11 11:22 ET

JMP Securities Maintains HOOKIPA Pharma(HOOK.US) With Buy Rating, Maintains Target Price $24

Moomoo NewsOct 31 03:32 ET

JMP Securities Maintains HOOKIPA Pharma(HOOK.US) With Buy Rating, Maintains Target Price $24

Moomoo NewsOct 30 15:31 ET

Analysts Offer Insights on Healthcare Companies: Trevi Therapeutics (TRVI), Replimune Group (REPL) and Hookipa Pharma (HOOK)

TipRanksAug 13 10:57 ET

HOOKIPA Pharma Analyst Ratings

BenzingaAug 9 14:47 ET

JMP Securities Maintains Market Outperform on HOOKIPA Pharma, Raises Price Target to $24

BenzingaAug 9 14:37 ET

Buy Rating and Price Target Increase for Hookipa Pharma Amid Clinical and Financial Progress

TipRanksAug 9 00:27 ET

HOOKIPA Pharma Analyst Ratings

BenzingaJul 26 14:16 ET

JMP Securities Maintains HOOKIPA Pharma(HOOK.US) With Buy Rating, Cuts Target Price to $23

Moomoo NewsJul 26 01:32 ET